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Abstract 
Vengust, M. 2010. Transvascular fluid dynamics in the pulmonary vasculature in 
horses at rest and during exercise. Doctoral dissertation. ISSN 1652-6880, ISBN 
978-91-576-7468-5 
 
Maximal  exercise  results  in  a  marked  increase  in  cardiac  output  (Q)  with 
consequent  adaptations  in  pulmonary  macro-  and  microvasculature.  These 
adaptations  change  pulmonary  hemodynamics  and  increase  fluid  and  solute 
movement  between  the  pulmonary  circulation  and  the  pulmonary  interstitium 
(across the lung). The purpose of this study was to determine pulmonary circulation 
transvascular fluid fluxes in a quantitative manner during exercise in horses. This 
was  determined  during  exercise  at  80%  VO2max  on  a high-speed treadmill until 
fatigue  without  any  medication,  with  acetazolamide  (Acz)  treatment,  and  with 
furosemide (Fur) treatment. 
Acetazolamide,  a  carbonic  anhydrase  (CA)  inhibitor,  has  several  effects  on 
pulmonary  vasculature  and  erythrocytes,  which  influence  pulmonary  circulation 
transvascular  fluid  fluxes  and  electrolyte  changes  across  the  lung.  These 
mechanisms are expressed through its ability to reduce vascular smooth muscle 
tone and contractility, and to attenuate hydration/dehydration of CO2 via the CA, 
Jacobs-Stewart cycle and chloride shift (Hamburger shift) inhibition.  
Furosemide causes diuresis. The consequence of diuresis is a decrease in plasma 
volume, right ventricular preload, and Q, which results in reduction in transmural 
hydrostatic  pressures  in  pulmonary  vasculature.  Reduction  of  transmural 
hydrostatic forces is the mechanism by which Fur is believed to attenuate exercise 
induced  pulmonary  hemorrhage.  Furosemide  has  also  a  dilatory  effect  on  the 
pulmonary vasculature, and it may affect the chloride shift across the erythrocyte 
membrane.   
Resting, exercise, and recovery arterial and mixed venous blood were sampled 
from race fit standarbred horses. Blood (BV) and erythrocyte volume (EV) changes 
across the lung were calculated from changes in plasma protein, hemoglobin and 
hematocrit. Cardiac output was calculated using Fick equation. Fluid flux across 
the  lung  was  quantified  based  on  changes  in  BV  and  EV  across  the  lung. 
Integrative  physicochemical  systems  approach  was  used  to  describe  acid  base 
changes across the lung. 
The overall findings of these studies showed that approximately 12 L/min or 4 % 
of Q moves from the pulmonary circulation into the pulmonary interstitium during 
exertion in horses. This volume, which left the pulmonary circulation, was derived 
primarily  from  the  reduction  of  erythrocytes’  volume  across  the  lung. 
Acetazolamide attenuated transvascular fluid fluxes in the pulmonary circulation  
through  attenuation  of  the  erythrocyte  volume  changes.  It  did  not  change  Q. 
Furosemide  did  not  affect  erythrocyte  volume  changes  and  transvascular  fluid 
fluxes in the pulmonary circulation, but reduced Q. Cardiac output during exercise 
is indicative of pulmonary capillary recruitment and/or dilatation coupled with the 
increase in the pulmonary surface area. From the results of our studies we conclude 
that pulmonary circulation transvascular fluid fluxes are regulated by erythrocyte 
volume  regulation.  Hydrostatic  transmural  gradients  across  the  pulmonary 
vasculature have a minor effect on pulmonary circulation transvascular fluid fluxes 
during exercise in horses.  
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Abbreviations 
Atot  weak electrolyte concentrations  
BV  blood volume 
CA  carbonic anhydrase 
COPD  chronic obstructive pulmonary disease 
EIPH  exercise induced pulmonary hemorrhage 
EV  erythrocyte volume 
FiO2  fraction of inspired oxygen in a gas mixture 
Fur  furosemide 
HPV  hypoxic pulmonary vasoconstriction 
JV-A  pulmonary circulation transvascular fluid fluxes 
PPA  pulmonary artery pressure 
PVR  pulmonary vascular  resistance  
Q  cardiac output 
SID  strong ion difference  
VCO2  rate of elimination of carbon dioxide 
VO2max  maximal oxygen uptake 
VO2peak  peak oxygen uptake   12  13
Introduction 
Pulmonary circulation fluid dynamics adaptation to exercise 
Maximal  exercise  results  in  marked  increase  in  cardiac  output  (Q) 
(Bevegard et al. 1963). Depending on the rate of rise of Q, pulmonary 
macro- and microvascular pressures increase accordingly (Wagner et al. 
1986; Groves et al. 1987, Schaffartzik et al. 1993, Newman et al. 1993). In 
concert with an increased macro- and microvascular pressures, blood flow 
redistribution occurs across the lung through the capillary recruitment and 
consequent  increase  in  the  pulmonary  surface  area  (Bake  et  al.  1968, 
Hlastala et al. 1996). Changes in pulmonary hemodynamics during exercise 
increase  fluid  and  solute movement across the alveolar-capillary barrier 
(Dexter  et  al.  1951,  Johnson  et  al.  1960).  Such  adaptations  can  be 
associated with the development of clinically apparent pulmonary edema 
(McKechnie  et  al.  1979)  or  the  subclinical  perivascular  edema  and/or 
parenchymal interstitial edema that worsens the pulmonary gas exchange 
in dogs (Younes et al. 1987), small ruminants (Coates et al. 1984), pigs 
(Schaffartzik et al. 1993), humans (Schaffartzik et al. 1992, McKenzie et 
al. 2005) and horses (West et al. 1993). 
Healthy animals and humans are capable of eliminating excessive lung 
fluid  during  strenuous  exercise  even  when  the  pulmonary  capillary 
hydrostatic  pressure  exceeds  the  edemagenic  threshold  (Wagner  et  al. 
1986,  Groves  et  al.  1987,  Newman  et  al.  1988,  Erickson  et  al.  1992, 
Newman et al. 1993, Manohar, 1993). Most of the excessive lung fluid is 
eliminated via the pulmonary lymph system (Staub et al. 1967, Mitzner and 
Sylvester 1986). During strenuous exercise the lung lymphatic flow rises 
several-fold above the baseline (Coates et al. 1984, Newman et al. 1988 
and 1993).    14
During intense exercise horses develop substantial hypoxemia (Wagner 
et al. 1989; Dempsey and Wagner 1999), which is believed to be the major 
mechanism  for  altered  pulmonary  fluid  fluxes.  Hypoxemia  results  in 
pulmonary vasoconstriction (hypoxic pulmonary vasoconstriction, HPV) of 
small  pulmonary  arteries,  which  increases  pulmonary  microvascular 
pressure and can, in turn, affect pulmonary capillary water permeability 
(Mairbaurl et al. 2002). Similar adaptations to hypoxemia are observed in 
high-altitude  intolerance  in  humans  and  animals  (Hecht  et  al.  1962, 
Maggiorini et al.  2001, Swenson et al. 2002) and other chronic respiratory 
diseases  such  as  chronic  obstructive  pulmonary  disease  (COPD), 
pulmonary fibrosis and obstructive sleep apnoea (Weitzenblum et al. 1981, 
Weir and Olschewski 2006).  
Hypoxemia stimulates a rise in the intracellular Ca2
+ concentration in 
pulmonary  vasculature  smooth  muscle  cells,  which  results  in  their 
consequent  vasoconstriction  (Jabr  et  al.  1997).  Hypoxic  pulmonary 
vasoconstriction  can  be  induced  with  (Furchgott  and  Zawadzki  1980, 
Stenmark and Mecham 1997) or without intact endothelium (Murray et al. 
1990) via various mechanisms, such as changes in membrane potential, 
increase in free cytosolic Ca2
+, increases in Ca2
+ sensitivity of contractile 
apparatus,  and  myosin  light  chain  phosphorylation  (Harder  et  al.  1985, 
Madden et al. 1985, Mauban et al. 2005). 
Starling’s hypothesis/principle 
Study of water movement across the capillary wall is based on Starling’s 
hypothesis  (Starling,  1896a),  which  states  that  a  balance  between  the 
hydrostatic and oncotic pressures across capillary walls holds the blood 
within  a  systemic  circulating  system  of  water-permeable  vessels.  In 
subsequent work by Landis (1927) Starling’s hypothesis was summarized 
with the following equation: 
Jv/A = Lp((Pc - Pi) - (πc - πi)),                                             (1) 
where Jv/A is relationship between the filtration or reabsorption rate of 
fluid per unit area of capillary wall, Lp is the hydraulic permeability of the 
capillary  wall,  Pc  is capillary pressure, Pi is hydrostatic pressure of the 
interstitial fluid, πc is oncotic pressure of plasma and πi is oncotic pressure 
of the interstitial fluid. 
Later, the work of Pappenheimer and Soto-Rivera (1948) transformed 
Starling’s  hypothesis  into  Starling’s  principle.  They  estimated  the 
quantitative relations between the arterial, venous and capillary pressures 
and  demonstrated  how  these  pressures  could  be  estimated  in  isolated   15
perfused hindlimbs of dogs and cats. Starling’s principle states that fluid 
movements across microvascular walls are determined by differences in 
hydrostatic and oncotic pressure.  
Starling’s  principle  is  used  to  explain  fluid  movement  across  the 
systemic circulation. However, it is less successfully utilized to understand 
fluid dynamics across the pulmonary circulation (Starling, 1896b; Michel, 
1997; Effros and Parker, 2009). 
A quantitative approach to acid-base chemistry 
The application of a physicochemical approach to the regulation of acid-
base status in intra- and extracellular space clarifies the link between fluid 
and electrolytes in physiological aqueous solutions (Stewart 1978, Stewart 
1981,  Stewart,  1983).  It  quantifies  the  relative  contributions  of  three 
independent  variables:  strong  ion  difference  (SID),  weak  electrolyte 
concentrations (Atot), and PCO2 to changes in dependent variables ([H
+], 
[HCO3
-]) in aqueous solutions. Changes in [H
+] can be achieved only by 
changing one or more of these three independent variables. The system is 
constrained  by  three  fundamental  physical  laws:  conservation  of  mass, 
electro-neutrality and the equilibrium constraints on dissociation reactions.  
Strong  ions  are  by  definition  electrolytes  that,  based  on  their  KA, 
completely dissociate in physiological aqueous solutions. The net effect of 
the presence of strong ions can be expressed in terms of the difference 
between  the  total  concentration  of  strong  base  cations  and  strong  acid 
anions. This is termed strong ion difference (SID): 
  
[SID] = S[strong cations] - S[strong anions]                                         (2) 
             
Weak electrolytes are only partially dissociated in H2O. Atot is used to 
express the total available anionic charge of the weak electrolytes, which 
consist of associated (HA) and dissociated (A
-) forms:  
 
[Atot] = [A
-] + [HA]                                                                                    (3) 
                                                                              
Carbon dioxide, a major end product of cell metabolism is moderately 
soluble  in  H2O.  The  amount  of  dissolved  CO2  (dCO2)  is  directly 
proportional  to  its  partial  pressure  (PCO2)  in  the  gas  phase  and  its 
solubility coefficient (SCO2): 
 
dCO2 = SCO2 (PCO2)                                                                                (4) 
   16
Dissolved CO2 reacts with H2O to form carbonic acid (H2CO3), which 
further  dissociates  into  H
+  and  HCO3
-  (hydration  of  CO2);  HCO3
-  then 
further dissociates to form H
+ and CO3
2-: 
 
H2O + CO2 ¬
CA®  H2CO3 « H
+ + HCO3
- « H
+ + CO3
2-.                      (5) 
 
During exercise CO2 moves down its partial pressure gradient from a 
working muscle into the circulation and is then removed via the respiratory 
system.   
Pharmacologic modulation of pulmonary transvascular fluid 
fluxes 
Pulmonary fluid dynamics can be selectively altered to determine in detail 
the events specific for physiology of pulmonary transvascular fluid fluxes 
or  to  determine  the  events associated with the pathophysiology of lung 
diseases.  For  the  purpose  of  this  thesis  pulmonary  transvascular  fluid 
fluxes  were  studied  after  acetazolamide  and  furosemide  administration. 
Both  drugs  have  very  specific  pharmacological  activities  and  are  used 
extensively clinically and experimentally to cause changes in pulmonary 
circulation that can alter transvascular fluid fluxes. 
Acetazolamide 
Acetazolamide  (N-(5Sulfamoyl-1,3,4-thiadiazol-2yl)  acetamide),  a 
carbonic  anhydrase  inhibitor,  has  several  clinical  and  investigational 
applications (Pocker and Watamori 1973). It has been previously used in 
horses  experimentally  to  evaluate  the  effect  of  acidosis  on  exercise 
responses  (Rose  et  al.  1990,  Hodgson  et  al.  1991).  Acetazolamide  also 
reduces  HPV  and  effects  pulmonary  vascular  resistance  (PVR)  (Lloyd 
1966; Rudolph and Yuan 1966, Morray et al. 1988).  
Carbonic  anhydrase  catalyzes  the  reversible  reaction  involving  the 
hydration/dehydration of CO2 (Maren 1967) as shown by: 
 
CO2 + H2O ¬
CA® H2CO3 « H
+ + HCO
-
3                                (6) 
 
  Carbonic  anhydrase  (CA)  catalyzes  the  hydration/dehydration  of  CO2 
and enhances the Jacobs Stewart cycle and chloride exchange several folds 
(Maren 1967, Kifor et al. 1993). Jacobs-Stewart cycle (Jacobs and Stewart 
1942) enables optimal CO2 elimination across the lung by transformation 
of intravascular HCO3
- to molecular CO2. Bicarbonate is transported into 
erythrocytes  in  exchange  for  Cl
-  by  band  3-mediated  anion  exchange   17
(Bretcher 1971). Hydrogen ion combines with intraerythrocytic HCO3
- to 
generate molecular CO2, which diffuses across the erythrocyte membrane 
and  capillary  endothelium  into  the  alveolar  space  (Jacobs  and  Stewart 
1942; Maren 1967). 
Carbonic anhydrase is metabolically closely interlinked with the activity 
of anion exchanger (AE1) forming a capnometabolon (Kifor et al. 1993). 
Therefore, inhibition of CA reduces the hydration/dehydration reaction of 
CO2  (Swenson  and  Maren,  1978)  and  decreases  AE1  transport  activity 
(Sterling et al. 2001). Impaired CO2 dehydration reaction and attenuation 
of  Cl
-  movement  across  the  erythrocyte  membrane  may  reduce 
transvascular fluid fluxes across the lung. 
In  horses  (Rose  et  al.  1990,  Hodgson  et  al.  1991)  and  humans 
(Kowalchuk et al. 1992, Kowalchuk et al. 1994), CA inhibition impairs 
CO2  transport  and  its  elimination  in  lungs.  Moreover,  chronic  CA 
inhibitors cause a state of systemic acidosis by blocking renal reabsorption 
of bicarbonate (metabolic acidosis) and tissue CO2 retention (respiratory 
acidosis)  (Swenson  1998,  Swenson  2000).  An  inadequate  or  absent 
hydration/dehydration  reaction  increases  the  rate  of  rise  of  PaCO2  and 
reduces rate of rise of VCO2 during exercise (Swenson and Maren, 1978; 
Rose et al. 1990, Hodgson et al. 1991, Kowalchuk et al. 1992, Kowalchuk 
et al. 1994).  
Independent of CA inhibition (Shimoda et al. 2007), Acz also reduces 
HPV (Deem et al. 2000, Hohne et al. 2004). Deem et al. (2000) observed 
that Acz reduces HPV by 50% and reduced the rate of rise by 40% in 
isolated  blood  perfused  rabbit  lung.  More  recently  Hohne  et  al.  (2004) 
reported a complete inhibition of HPV in dogs exposed to FiO2 of 0.10 
after  treatment  with  Acz.  Acetazolamide  prevents  a  rise  in  [Ca2
+]  in 
response to hypoxia in pulmonary artery smooth muscle cells (Hohne et al. 
2007).  
Acetazolamide,  through  CA  inhibition,  results  in  venous  and arterial 
hypercapnia.  Reports  on  the  effects  of  hypercapnia  and  acidosis  on 
pulmonary  vasoconstriction  are  contradictive.  Gordon  et  al.  (1999) 
reported that hypercapnic acidosis in intact newborn piglets has no effect 
on  hypoxic  pulmonary  artery  pressure  (PPA)  under  acute  conditions, 
whereas 60-80 min of sustained acidosis resulted in a marked increase in 
both  baseline  and  hypoxic  pulmonary  vascular  resistance  (PVR). 
Extracellular acidosis has been shown to increase PVR in isolated dogs’ 
pulmonary lobes (Lloyd 1966), and in both, calves (Rudolph and Yuan 
1966) and children (Morray et al. 1988), with congenital heart disease and 
associated pulmonary hypertension.    18
The slowing of the rate of CO2 hydration/dehydration by Acz (Swenson 
and  Maren,  1978)  also  results  in  increase  in  intracellular  CO2  and 
intracellular [H
+]. Raffestin and McMurtry (1987) reported that increase in 
pulmonary smooth muscle intracellular [H
+] also decreases PVR in isolated 
rats’  lungs.  However,  Shimoda  et  al.  (2007)  reported  that  the  effect  of 
increased  intracellular  [H
+]  on  PVR  is  independent  of  mechanisms that 
involve  pulmonary  smooth  muscle  cell  intracellular  acidification  or  a 
change in its membrane potential.      
Acetazolamide  activity  through  CA  inhibition,  HPV  reduction  and 
influence  on  PVR  can  influence  pulmonary  circulation  macro-  and 
microvascular  pressures.  The  purpose  of  this  study  was  to  ascertain 
whether  indeed  a  reduction  in  pulmonary  vascular  pressures  could 
influence pulmonary circulation transvascular fluid fluxes. 
Furosemide 
Furosemide (Fur) (4-chloro-N-[2-furylmethyl]-5-sulfamoylanthranilic acid) 
is a rapidly acting loop diuretic, which is used extensively to modulate 
fluid balance throughout the body (Kirkendall and Stein 1968, Kim et al. 
1971). Loop diuretics are actively secreted into the proximal renal tubules 
and inhibit the active re-absorption of electrolytes in the thick ascending 
limb of the loop of Henle (Odlind 1979). These drugs act on the luminal 
surface of the epithelial cells to inhibit Na
+, K
+, and Cl
- transport, which 
leads to a reduced renal interstitial hypertonicity, the reduction of water 
absorption, and diuresis (Greger and Wangemann 1987). 
  Furosemide  is  widely  prescribed  for  management  of  racehorses 
experiencing  exercise  induced  pulmonary  hemorrhage  (EIPH)  (Arthur 
1991). It is usually administered at least 4 h before race-time, and the dose, 
depending on the administrative racing jurisdiction, is limited to 250 or 
500 mg without adjustment for body weight (Arthur 1991). Hinchcliff et al. 
(2009) reported that Fur at a dose of 500 mg decreased the incidence and 
the severity of EIPH in Thoroughbreds racers. The effect of Fur on EIPH is 
dependent on the dose and the time of administration before the exertion 
(Lester et al. 1999). Premedication with furosemide may help decrease or 
prevent from occurrence of EIPH through 1) the effect of diuresis on blood 
and plasma volume (Hinchcliff et al. 1991, Hopper et al. 1991, Hinchcliff 
and McKeever 1998), 2) Fur direct effect on the pulmonary vasculature 
(Lundergan et al. 1988, Greenberg et al. 1994, Hinchcliff and McKeever 
1998), and 3) furosemide-induced bronchodilatation (Olsen et al. 1992a, 
Rubie  et  al.  1993,  Almirall  et  al.  1997).  Additionally,  Fur  can  also 
influence  erythrocytes’  fluid  release  across  the  lung.  Thus  the  various   19
beneficial  effects  of  Fur  on  EIPH,  as  discussed  further  in  detail,  may 
influence pulmonary circulation transvascular fluid fluxes. 
  The diuretic effect of Fur causes a reduction in blood and plasma volume 
in  horses  (Hopper  et  al.  1991,  Hinchcliff  et  al.  1991,  1996),  which 
decreases the right atrial pressure and pulmonary arterial pressure during 
exertion  (Manohar  et  al.  1994,  Parker  et  al.  1995).  These  physical 
alterations  translate  into  reduction  in  pulmonary  artery  pressure  and 
diminished  transmural  hydrostatic  pressures  in  pulmonary  capillaries 
(Manohar 1993, 1994, Manohar et al. 1994, Hinchcliff et al. 1996). Thus, 
the reduction in transmural pulmonary capillary pressure (intra-capillary 
pressure minus the perivascular (alveolar) pressure) is believed to attenuate 
stress failure of pulmonary capillaries and thereby reduces the incidence 
and severity of EIPH (Manohar 1993, 1994, Manohar et al. 1994, West et 
al. 1993, Manohar and Goetz 1996). Reduction in transmural (hydrostatic) 
pulmonary  capillary  pressure  can  also  affect  pulmonary  circulation 
transvascular fluid fluxes based on the Starling’s hypothesis. 
  Direct  pulmonary  vasodilatation  and  improved  pulmonary  compliance 
effects  of  Fur  (and  other  diuretic  drugs)  is  probably  related  to  1) 
prostaglandin  release and the initial pressor actions to activation of the 
renin-angiotensin system (Silke 1993, Lundergan et al. 1988) and 2) to an 
effect  on  Na
+/K
+/Cl
-  co-transport  or  chloride-mediated  refilling  of 
intracellular  calcium  stores  (Greenberg  et  al.  1994).  It  should  be 
emphasized that hemodynamic properties of Fur are beneficial at rest and 
in patients with mild physical impairments due to ventricular dysfunction. 
The actions during exercise, however, are more varied and less beneficial 
(Silke  1993).  Nevertheless,  it  is  prudent  to  evaluate  the  option  that 
pulmonary vasodilatation and improved pulmonary compliance caused by 
treatment  with  Fur  may  cause  changes  in  pulmonary  circulation 
transvascular fluid fluxes in horses during submaximal exercise. 
Furosemide has a weak bronchodilator effect when inhaled in asthmatic 
humans (Bianco et al. 1988) or given intravenously to horses with (Rubie 
et  al.  1993)  or  without  the  pulmonary  obstructive  disease  (Olsen  et  al. 
1992a).  The  bronchodilatory  effect  of  furosemide  is  mediated  through 
prostanoid production (Olsen et al. 1992b, Rubie et al. 1993, Almirall et al. 
1997).  Bronchodilation  reduces  the  effect  of  exercise  induced  alveolar 
hypoxia and consequent pulmonary vasoconstriction of small pulmonary 
arteries, which increase pulmonary microvascular pressure (Mairbaurl et 
al. 2002). Increased pulmonary microvascular pressure reduces transmural 
hydrostatic forces, which are traditionally believed to be the regulator of 
pulmonary fluid dynamics.  
  The nonselective inhibition of Na
+/K
+/2Cl
- by Fur was also observed in 
erythrocytes;  however,  inhibition  of  Na
+/K
+/2Cl
-  cotransport  does  not   20
influence  erythrocyte  volume  regulation  (Kracke  and  Dunham  1987). 
Furosemide  can,  however,  affect  the  erythrocyte  fluid  volume  by 
attenuating  the  chloride  shift  (Hamburger  shift)  across  the  erythrocyte 
membrane  (Bretcher  1971,  Lambert  and  Lowe  1980,  Guizouarn  et  al. 
2001).  Erythrocyte  volume  regulation  greatly  contributes  to  pulmonary 
circulation transvascular fluid dynamics; therefore, Fur attenuation of the 
chloride shift may have significant effect in vascular fluid fluxes across the 
lung. 
Problem identification 
Paper I 
At the outset of this thesis work fluid movement across the pulmonary 
circulation at rest and during exercise had not been quantified. Lymph flow 
studies  had  provided  some  evidence  on  pulmonary  circulation 
transvascular fluid fluxes. Even though the pulmonary lymph flow is mixed 
with lymph flow from nonpulmonary tissues (Demling and Gunter 1982; 
Drake  et  al.  1986)  and  the  conducting  airways  (Wagner  et  al.  1998), 
increased exchange of fluid across pulmonary capillaries correlates with 
increased lymph flow from lungs (Coates et al. 1984) 
Fluid movement across the pulmonary circulation cannot be quantified 
using the Starling’s equation. This is because of several factors, including 
inability  to  define  forces  governing  these  events  in  lung compartments, 
lung compartments are not fully recognized/determined and water transport 
across the membrane is also regulated independently of solute transport 
(aquaporins)  (King  et  al.  2004).  In  addition,  pulmonary  circulation  is 
protected  from  fluid  leakage/  edema  formation  by  several  mechanisms, 
which are properties solely found in the pulmonary vasculature and lacking 
in  systemic  vessels  (Effros  and  Parker  2009).  Based  on  that,  a  simple 
Starling model cannot be readily applied to study pulmonary circulation 
transvascular  fluid  fluxes  (King  et  al.  2004,  Effros  and  Parker  2009). 
Therefore, we conducted a study where fluid movement across the across 
the  lung  was  quantitatively  assessed  by  comparison  of  blood  volume 
differences  between  mixed  venous  blood  and  arterial  blood  (across  the 
lung) in horses at rest and during exercise.  
Paper II 
Hypoxemia indirectly contributes to fluid accumulation in the pulmonary 
interstitium (Mairbaurl et al. 2002), which is most often seen in HPV of the 
acute high-altitude intolerance in humans (Maggiorini et al. 2001, Swenson   21
et al. 2002). Hypoxic pulmonary vasoconstriction can be managed with 
carbonic  anhydrase  inhibitors,  such  as  Acz.  Acetazolamide  exerts  its 
therapeutic  effects  through  reduction  or  prevention  of  vasoconstrictory 
effects  of  hypoxemia  on  pulmonary  microvasculature  (Schoene  et  al. 
2001).  It  will  also  cause  CO2  retention  and  acidosis.  It  has  been 
documented  that  hypercapnia  can  per  se  impair  gas  exchange  with  its 
influence on pulmonary arterial pressure (Brimioulle et al. 1991). Together 
with increased [H
+] it has a prominent role in generalized edema formation 
in human COPD patients (Karadag et al. 2004); however, it should not 
result in accumulation of fluid in lungs (Haberkern and Bland 1981).  
The  ability  of  Acz  to  reduce  or  prevent  vasoconstrictory  effects  of 
hypoxemia on pulmonary microvasculature is already established (Schoene 
et al. 2001). However, CO2 retention and acidosis influence on lung fluid 
balance in horses (and other mammals) at rest and during exertion (under 
hypoxemic conditions) is not known. Thus, the research plan to study this 
was undertaken in paper II. 
Paper III 
Effects of CO2 retention and acidosis on acid base and electrolyte balance 
across the lung in pulmonary circulation in horses or other animals or a 
human  at rest and during exertion have also not yet been described. A 
quantitative approach to acid-base chemistry was used to determine the 
electrolyte  changes  across  the  lung.  Another  objective  was  to  link 
pulmonary gas exchange and electrolyte changes to pulmonary circulation 
transvascular fluid fluxes. 
Using  the  integrated physicochemical systems approach, it is possible 
within  each  fluid  compartment  to  describe  the  influence  of  three 
independent  variables,  strong  ion  difference  (SID),  PCO2  and  total 
concentrations of weak acids and bases (Atot) on [H
+] and [HCO3
-], which 
are  considered  dependent  variables  (Stewart  1983).  In  paper  III  we 
hypothesized that Hamburger (chloride) shift and the Jacobs-Stewart cycle 
play a critical role in acid base homeostasis across the lung.  
Paper IV 
Furosemide  may  attenuate  EIPH  through  a  reduction  in  transmural 
hydrostatic  pressures  in  pulmonary  capillaries,  which  is  attributed  to 
decrease  in  plasma  volume  and  right  ventricular  preload  as  a  result  of 
diuresis (Hinchcliff et al. 1991; Hinchcliff and McKeever 1998), dilatory 
effect of Fur on the pulmonary vasculature (Lundergan et al. 1988, Olsen 
et al. 1992a, Greenberg et al. 1994, Hinchcliff and McKeever, 1998) and   22
furosemide-induced bronchodilatation (Rubie et al. 1993, Almirall et al. 
1997). 
 In addition, Fur may affect the chloride shift (Hamburger shift) across 
the  erythrocyte  membrane  via  the  Cl
-/HCO3
-  exchanger  (AE1,  Band  3) 
(Bretcher  1971,  Lambert  and  Lowe  1980),  which  is  a  part  of  the 
erythrocyte volume regulation mechanisms (Guizouarn et al. 2001). Thus, 
the action of Fur to decrease transmural hydrostatic pressures in pulmonary 
capillaries  and  attenuation  of  the  chloride  shift  are  both  potential 
mechanisms by which Fur may reduce or attenuate fluid fluxes across the 
lung.  Therefore,  in  conducting  the  experiments  for  paper  IV,  we 
hypothesized  that  pre-exercise  treatment  with  Fur  will  attenuate 
transpulmonary fluid fluxes in horses during intense exercise. 
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Aims of the study 
·  To quantify transvascular fluid fluxes in the pulmonary circulation 
at rest and during exercise in horses, 
·  To quantifiably determine adaptation of transvascular fluid fluxes 
in the pulmonary circulation at rest and during exercise in horses 
after  treatment  with  the  carbonic    anhydrase  inhibitor 
acetazolamide, 
·  To determine blood gas and electrolyte adaptation across the lung 
during exercise in horses after treatment with acetazolamide, 
·  To determine the interrelation between acid base and electrolyte 
balance and pulmonary circulation transvascular fluid fluxes, 
·  To quantifiably determine adaptation of transvascular fluid fluxes 
in the pulmonary circulation at rest and during exercise in horses 
after treatment with furosemide. 
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Materials and methods 
Six race fit Standardbred horses were used for each study. Different horses 
were recruited for each experiment with owner/trainer consent. The study 
protocols were approved by the Animal Care committee according to the 
Guide to the Care and Use of Experimental Animals (Canadian Council on 
Animal Care, Ottawa, Ontario). All horses were returned to owners healthy 
and resumed their normal training and racing activities. 
  All studies (paper I to IV) had similar experimental protocols for exercise 
regimens and sampling, apart from administration of Acz (Paper II, III) or 
furosemide (Paper IV). 
Pre-Experimental Protocol  
Horses  were  familiarized  to  the  treadmill  over  a  period  of  one  week. 
During the first three days horses were given repeated walking exercise on 
the treadmill for 20 min. daily (15 min. walk, 5 min. slow pace) at 10% 
treadmill  inclination,  followed  by  two  days  of  light  exercise  with  the 
respiratory  mask.  Before  every  treadmill  exercise  horses were weighed, 
fitted with a safety harness, hobbles, and heart rate meter (Equistat Model 
HR-8 A, EQB Inc., Unionville, PA, USA).  
On  day  six  peak  O2  uptake  (VO2peak)  was  determined  for  each horse, 
which comprised three treadmill exercise periods: warm-up, incremental 
exercise, and recovery. During the warm-up period the horses walked on 
horizontal treadmill with no incline for 5 min at 2-3 m/s and then trotted 
for 5 min at 4-5 m/s. At the end of this 10 min warming-up period the 
treadmill  was  inclined  to  10%  and  the  speed  increased  to  8  m/s.  The 
incremental exercise then consisted of a stepwise increase of velocity of 1 
m/s every 60 s. An open flow through system was used for collection of 
pulmonary gases throughout the entire exercise protocol. Peak O2 uptake 
was determined as the point at which no further increase in VO2 occurred,   26
despite an increase in speed, or a level of exercise where the horse could 
no longer maintain pace with the treadmill speed. Three days following the 
determination of VO2peak, the horses were hand walked for 15 min daily. 
The experimental protocol was then conducted on the fourth day. 
Experimental protocol  
Prior to experiment, the of the mid cervical region over both jugular veins 
was clipped, desensitized with lidocaine 2.5% and prilocaine 2.5% cream 
(lidocaine  2.5%  and  prilocaine  2.5%;  AstraZeneca  Pharmaceuticals  LP, 
Wilmington, DE, USA) and aseptically prepared. Pulmonary Swan-Ganz 
catheter (Baxter Healthcare Corp., Irvine, CA, USA) and a 150 cm long 
central  venous  polyethylene  blood  catheter  (#240,  Becton  Dickinson,
 
Sparks, MD, USA) were placed aseptically via the left and right jugular 
vein into the pulmonary artery for mixed central venous blood sampling 
and core body temperature measurements. Correct catheter placement was 
ascertained  by  observing  characteristic  pressure  waveforms  on  an 
oscilloscope (Criticare 1100, Criticare Systems Inc., Waukesha, WI, USA). 
A  20  Gauge  catheter  (Insyte-W, Infusion Therapy Systems Inc., Sandy, 
UT, USA) was inserted into the facial or transverse facial artery. A 30-cm 
long  extension  tubing  with  a  three  way  stopcock  was  connected  to 
intravenous  and  arterial  catheters.  Catheters  and  extension  tubing  were 
sutured to the skin. 
Horses  stood  still  on  the  treadmill  until  their  heart  rate  reached  their 
resting  value  and  then  were  warmed-up  as  described  in  the  pre-
experimental protocol of the VO2peak determination.  Following the warm-
up treadmill speed was set to the velocity and slope inducing 80% of the 
VO2peak. Horses were then exercised until fatigued. During recovery horses 
were walked on the treadmill at 1.7 m/sec for 15 min.  
Acetazolamide treatment experiment (paper II and III)  
Horses were given Acz (Apo-acetazolamide, Apotex Inc., Ontario, Canada) 
orally at a dose of 10 mg/kg of BW TID for three days or were not treated 
(control). Acetozolamide tablets were crushed and mixed with a mixture of 
molasses  and  corn  oil,  and  administered  orally  with  a  Toomey  syringe 
(C.R. Bard Inc., Covington, GA, USA). Thirty min. before the treadmill 
protocol horses were given 30 mg/kg of BW of Acz mixed in 8 ml of tap 
water/kg of BW via a nasogastric tube or were administered tap water only 
(control).    27
Furosemide treatment experiment (paper IV) 
Horses were given 250 mg of furosemide i.v. or placebo intravenously four 
hours prior to the treadmill protocol. 
Pulmonary gas collection  
Pulmonary gas exchange was measured at rest, during exercise, and during 
the recovery period. Before exercise the respiratory mask was fitted on the 
horse’s  nose.  An  open  flow  through  system  was  used  for  collection  of 
expired gases throughout the entire exercise protocol (Wagner et al. 1989). 
The expired gas was drawn into the O2 analyzer (Ametek, Model S-3A/1, 
Pittsburgh, PA, USA), which measured the concentration of inspired O2. 
Inspired O2 was recorded in 10-second periods throughout the experiment. 
For analysis the average of three measurements in a 30 second period was 
used, which coincided with blood sampling intervals. 
Blood sampling and blood analysis  
Resting  arterial  and  mixed  venous  blood  samples  were  collected 
simultaneously under anaerobic conditions twice in a five-minute interval. 
Further  sampling  was  performed  in  60  s  intervals  during  the  exercise 
period until fatigue. During the recovery period sampling was performed 
immediately after the treadmill was stopped (0 min) and then at one, two, 
three,  five,  10,  and  15  minutes  into  the  recovery  period.  Prior  to  each 
sampling 10 mL of blood was withdrawn from catheters and discarded. 
Blood  samples  were  collected  into  lithium-heparinized  syringes  (S-
Monovette, Sarstedt AG and Co, Nümbrecht, Germany), stored on ice, and 
analyzed in duplicate with the Stat Profile M Analyzer (Nova Biomedical 
Corporation, Waltham, MA, USA) immediately after the treadmill protocol 
ended.  Stat  Profile  M  Analyzer  uses  conductivity  for  hematocrit, 
conductivity/reflectance for haemoglobin and O2 saturation analysis, ion 
selective electrodes for analysis of Na
+, K
+, Cl
-, as well as for pH and 
PCO2; amperometry for PO2 and La
-. Blood O2 content was calculated from 
the O2 saturation and the Hb concentration using standard equations. Total 
plasma protein was measured using a clinical refractometer (Attago 331, 
Attago, Tokyo, Japan). The pH, PCO2, HCO3
- and PO2 sample values were 
corrected for the horses’ core body temperature (Model COM-2, Baxter 
Healthcare Corp., Irvine, CA, USA). 
For  erythrocyte  and  whole  blood  electrolyte  analyses,  blood  samples 
were repeatedly frozen (–80
oC) and thawed (room temperature) to induce 
erythrocyte lyses.   28
Calculations   
Plasma  volume  changes  across  the  lung  (DPVv-a)  were  calculated  from 
changes in plasma protein [PP] at the same time point from central venous 
to arterial blood (across the lung) (Dill and Costill 1974): 
%DPVv-a = (([PPv] – [PPa]) / [PPv]) x 100,                                (7) 
where [PPv] is the plasma protein concentration in venous and [PPa] the 
plasma protein concentration in arterial blood. To account for changes in 
plasma volume relative to hematocrit (Hct), the equation 1 was adjusted for 
changes in the Hct across the lungs. 
%DHctPVv-a  = (([PPv] x (1-Hctv) – [PPa] x (1-Hcta)) / [PPv]) x 100       (8)  
where %DHctPVv-a   is the plasma volume change relative to Hct changes 
from central venous (Hctv) to arterial (Hcta) blood. 
Changes in erythrocyte volume (DEVv-a) across the lungs were calculated 
from changes in hemoglobin [Hb] and hematocrit [Hct] in venous ([Hbv], 
[Hctv]) and arterial blood ([Hba], [Hcta]) (Costill et al. 1974): 
%DEVv-a = ((([Hbv] / [Hba]) x (Hcta / Hctv)) – 1) x 100                     (9) 
For calculation of the blood volume (BV) the %DEVv-a was adjusted for 
Hct changes across the lung: 
%DHctEVv-a = ((([Hbv] / [Hba]) x (Hcta / Hctv) x Hcta) – Hctv) x 100      (10) 
Blood  volume  changes  across  the  lung  were  then  measured  from  
DHctPVv-a and DHctEVv-a:  
%DBVv-a = ((([PPv] x (1-Hctv) – [PPa] x (1-Hcta)) / [PPv]) x 100) + ((([Hbv] 
/ [Hba]) x (Hcta / Hctv) x Hcta) – Hctv) x 100                             (11) 
Cardiac output (L/min) was calculated based on the Fick principle using 
VO2 and blood O2 content from central venous and arterial blood. Fluid 
flux  (JV-A  L/min)  across  the  lung  was  then  quantified  based  on  Q  and 
%∆BV: 
JV-A = (Q x %∆BV).                                                       (12) 
Plasma [H
+] was calculated from the measured pH as the antilog.  
Strong ion difference was calculated as the sum of strong cations minus 
the sum of the strong anions: 
 [SID] = ([Na
+] + [K
+]) – ([Cl
-] + [La
-])                                  (13)   29
Plasma [Atot] was calculated using a conversion factor of 0.21 mmol/L 
of plasma protein (Staempfli et al. 1999).  
Erythrocyte ion concentrations were calculated from whole blood (wb) 
and plasma (p) ion concentration according to Buono and Yeager (1986) 
and McKelvie et al. (1991). 
e[ion] = (wb[ion] – (pl[ion] x (1 – Hct))) x Hct
-1                              (14) 
All venoarterial differences for plasma ions and proteins were corrected 
for DPVv-a using the equation (McKenna et al. 1997):  
[Ion]V-A = ([Ion]v / (1 + (DPVV-A)) – [Ion]a                               (15) 
A similar correction was made for erythrocyte ion concentration using 
DEVV-A (McKenna et al. 1997). 
Study design and statistical analysis 
A cross over design was used when comparisons were made between 
control and treatment, with horses serving as their own control. The 
furosemide study was done in a double-blinded fashion 
All data were normally distributed as verified with Shapiro-Wilks test. 
Effects of treatment and exercise (time) as well as treatment and exercise 
(time) interaction on variables were analyzed using a two-way repeated-
measures ANOVA. Treatment and exercise (time) were considered as 
repeated factors.  
Pair-wise comparison with Bonferroni adjustment was used only to 
assess statistical significance of differences between rest and exercise 
times and between parameters of different treatments at the same specific 
time point.  
Overall effect of treatment with Acz or Fur was defined at rest, during 
exercise (from first minute to fatigue) and recovery (from first minute of 
recovery till the end of recovery). Repeated-measures two-way ANOVA 
was used to compare overall effects between treatments.     
A statistical significance level of P <0.05 was used and data are 
expressed as means ±SE. 
Statistical analysis was performed with SPSS statistics 17.0 (SPSS Inc., 
Chicago, IL, USA). 
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Results and discussion 
Transvascular fluid flux from the pulmonary vasculature at rest 
and during exercise in horses (paper I) 
Transvascular fluxes in lungs of horses (hereafter identified as JV-A) during 
exercise reached approximately 4% of the Q or 12 L/min (figure 1).  
 
Figure 1. Fluid flux from the pulmonary vasculature (JV-A) at rest, during exercise and 
recovery. Values are means ± SE (n=6). *, different from rest (P < 0.05). Ftg, fatigue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the present study it was established that erythrocyte volume decrease 
(erythrocyte volume release) across the lung was an important contributor 
to whole fluid flux from the pulmonary vasculature (figure 2). This was 
surprising, because this study’s hypothesis was derived from the ability of 
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horses to develop and sustain high pulmonary macro- and microvascular 
pressures during exercise (Slonim et al. 1954; Elkins and Milnor, 1971; 
Wagner et al. 1986; Younes et al. 1987; Newman et al. 1993). Those are 
derived  from  increases  in  PPA  during  exertion  (Erickson  et  al.  1992; 
Manohar, 1993; Wagner et al. 1989, Wilkins et al. 2001), which translates 
into a relatively high pulmonary capillary pressure (Sinha et al. 1996) and 
consequent  increase  in  the  transvascular  fluid  filtration  across  the  lung 
(Sinha et al. 1996).  
 
Figure 2. Fluid flux across the lung from erythrocytes  (JEV) at rest, during exercise and 
recovery. Values are means ± SE (n=6). *, different from rest (P < 0.05). Ftg, fatigue. 
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In paper I our results were interpreted classically, through changes in 
pulmonary  circulation  transmural  hydrostatic  forces.  We  concluded  that 
the  pulmonary  circulation  transvascular  fluid  fluxes  are  caused  by  1) 
pulmonary capillary recruitment and/or dilatation coupled with the increase 
in the pulmonary surface area (Bake et al. 1968, Hlastala et al. 1996), 2) 
increased pulmonary microvascular pressures (Sinha et al. 1996) and 3) 
changes in the pulmonary transcapillary gradients (Bland and McMillan 
1977),  and,  as  determined  in  this  study,  erythrocyte  volume 
decrease/erythrocyte fluid release. Pulmonary transvascular fluxes increase 
as a function of the net transvascular driving pressure: hydrostatic pressure 
gradient minus protein osmotic pressure gradient (Starling 1896a,b, Bland 
and McMillan 1977). Hydrostatic pressures are traditionally accepted to be 
the important determinant of pressure and fluid dynamics in the pulmonary 
circulation.  However,  the  equilibrium  between  fluid  and  solutes  in 
pulmonary  vasculature  during  exercise  became  altered  with  active  fluid   33
release from erythrocytes. The dilution of plasma protein reduced plasma 
colloid  osmotic  pressure  gradient,  which,  assisted  with  the  increased 
hydrostatic pressure, favored the fluid out of the pulmonary vasculature 
restoring  the  transvascular  gradient  to  its  equilibrate  state.  Therefore, 
oncotic forces have an important function along with hydrostatic forces in 
the  extent  of  fluid  movement  from  the  pulmonary  vasculature  during 
exercise.  
Effects of chronic acetazolamide administration on fluid flux 
from the pulmonary vasculature at rest and during exercise in 
horses (paper II) 
After quantification of pulmonary transvascular fluid fluxes in paper I the 
objective  was  put  forward  to  better  define  the  physiologic  mechanisms 
related  to  JV-A  through  evaluating  its  response  to  treatment  with  Acz 
(AczTr).  Acetazolamide  reduces  or  prevents  vasoconstrictory  effects  of 
hypoxemia  on  pulmonary  microvasculature  (Schoene  et  al.  2001). 
Hypoxemia  is  common  in  horses  during  sub-  and  maximal  exercise.  In 
addition, chronic Acz administration causes CA inhibition, which in turn 
induces  hypercapnia.  Hypercapnia  per  se  and  in  combination  with 
metabolic acidosis can express vasoconstrictory or vasodilatory effects on 
pulmonary  vasculature  (Brimioulle  et  al.  1991),  and  thereby  influence 
pulmonary  transvascular  fluid  fluxes.  Disorders  that  may  cause 
hypercapnia are mostly associated with diseases of lungs, the airways, or 
both. However, hypercapnia not only arises from the respiratory system but 
also  from  diseases  affecting  the  neural,  muscular,  chest-wall,  and 
circulatory  components  of  the  respiratory  system.  Regardless  of  the 
etiology,  animals  and  humans  still  exercise,  at  intensities  that  cause  a 
variable  degree  of  hypoxemia,  under  pathologic  conditions  that  can 
enhance  or  cause  severe  hypercapnia.  Understanding  of  the  effect  of 
hypoxemia, hypercapnia and metabolic acidosis on pulmonary circulation 
transvascular fluid fluxes is also important for more severely ill patients 
where lung water dynamics can be compromised even in the absence of 
exercise.  
At rest JV-A was not different between Con and AczTr. However, during 
exercise,  JV-A  increased  to  a  similar  level  that  was  reported  in  paper  I. 
Transvascular fluid fluxes were attenuated in AczTr. Cardiac output was 
not different between control and AczTr (figure 3). 
   34
 
Figure 3. Fluid flux from the pulmonary vasculature (JV-A) at rest, during exercise and 
recovery in control (Con) and chronic acetazolamide treatment (AczTr). Values are means 
± SE (n=6). Ftg, fatigue. 
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In our first publication we determined that erythrocytes, through their 
volume  regulation,  contribute  significantly  to  pulmonary  circulation 
transvascular fluid fluxes. In this study the erythrocyte fluid release across 
the lung was diminished by chronic treatment with Acz (figure 4). 
 
Figure 4. Erythrocyte volume changes across the lung at rest, during exercise and recovery 
in control (Con) and chronic acetazolamide treatment (AczTr). All values are means ± SE 
(n=6). Ftg, fatigue. 
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Because Q was not affected by Acz it is possible to conclude that the 
effects  of  hypoxemia,  hypercapnia  and  acidosis  together  on  pulmonary 
vasoconstriction  during  exercise  did  not  have  a  significant  effect  on 
pulmonary  circulation  pulmonary  macro-  and  microvascular  pressures, 
which would consequently diminish pulmonary circulation transvascular 
fluid fluxes.  However, chronic treatment with Acz affected erythrocyte 
volume  regulation/erythrocyte  fluid  release  across  the  lung.  The 
mechanism affecting the fluid release from erythrocytes during exercise 
after  AczTr  cannot  be  determined  from  data  gathered  in  this  study. 
However,  there  are  some  mechanisms  that,  when  challenged  with 
hypoxemia,  hypercapnia  and  acidosis,  could  potentially  disable 
erythrocytes from reducing their volume across the lung, including: 
1.  Increased intracellular [H
+] in the erythrocytes would stimulated Na
+/H
+ 
pump on the erythrocyte plasma membrane, which contributes to fluid 
accumulation in erythrocytes and the erythrocyte volume increase to the 
extent that K
+/Cl
- co-transport, a part of the system that contributes to 
erythrocyte volume decrease (Honess et al. 1996, Speake et al. 1997, 
Gibson et al. 2000), could not compensate for on the passage through 
the  lung  capillary  bed.  K
+/Cl
-  co-transport  should  be 
activated/stimulated and the Na
+/H
+ pump disabled/depressed in blood 
passing pulmonary capillaries (Honess et al. 1996, Speake et al. 1997, 
Gibson et al. 2000), 
2.  Erythrocyte volume regulation could have been affected by prevention 
of  fluid  release  from  the  pulmonary  circulation  into  pulmonary 
interstitial (due to possible direct effect of Acz on pulmonary vascular 
wall permeability) causing osmolality forces in plasma unfavourable for 
erythrocytes to complete their volume decrease/fluid release, and 
3.  Slowing  the  rate  of  CO2/HCO3
−/H
+  interconversion  increased  the 
fraction  of  total  CO2  in  the  erythrocyte  preventing  erythrocyte  fluid 
release, because of increased intracellular osmolality.  
 
Regardless of the cause or combination of causes, pulmonary circulation 
transvascular fluid fluxes commence simultaneously with respiratory gas 
exchange.  They can be affected by factors that influence or interfere with 
respiratory  gas  exchange  mechanisms.  However,  pulmonary  circulation 
transvascular  fluid  fluxes  appear  to  be  quite  refractory  to  changes  in 
pulmonary circulation pressures when fluid dynamics across the lung are 
subject to an acute event such as exercise.    36
Effects of chronic acetazolamide administration on gas 
exchange and acid-base control in pulmonary circulation in 
exercising horses (paper III) 
In this study we evaluated 1) effects of CO2 retention and acidosis on acid 
base  and  electrolyte  balance  across  the  lung  and  2)  the  interrelation 
between  acid  base  and  electrolyte  balance  and  pulmonary  circulation 
transvascular fluid fluxes. We hypothesized that Hamburger shift and the 
Jacobs-Stewart  cycle  play  a  critical  role  in  acid  base  homeostasis  and 
volume changes across the lung.  
In this study we used the integrated physicochemical systems approach 
to describe acid base changes across the lung in pulmonary circulation in 
exercising horses without (control) and with CA inhibition (with related 
metabolic  and  respiratory  acidosis).  The  physicochemical  systems 
approach was used to describe the influence of three independent variables, 
strong ion difference (SID), PCO2 and total concentrations of weak acids 
and  bases  (Atot)  on  [H
+]  and    [HCO3
-],  within  each  fluid  compartment 
(Stewart 1983).  
The full data arrangement in tables in this study was very extensive. For 
a comprehensive review of results please refer to paper III. In summary 
however, the following most significant conclusions can be made:  
1.  Chronic  CA  inhibition  affected  exercise  time  to  fatigue:  exercise 
duration at 80% VO2peak was significantly shorter in AczTr (2.6 ±0.2 
min) compared to Con (4.7 ±0.2 min, P < 0.0001),  
2.  Chronic  CA  inhibition  greatly  influenced  the  acid  base  homeostasis 
across the lung, 
3.  Acid base disturbance across the lung was related to retention of CO2 
and inhibition of Cl
- flux across the erythrocyte membrane,  
4.  Volume  regulation  of  erythrocytes  and  acid  base  changes  across  the 
lung are linked to each other, and  
5.  Atot and La
- have no influence on acid base status across the lung. 
 
During  exercise  AczTr  attenuated  the  hydration/dehydration  reaction 
and  slowed  the  equilibration  between  CO2  species  in  pulmonary 
capillaries,  which  further  on  increased  PaCO2  (Swenson  1998,  Swenson 
2000). The slowing of the CA reaction means that equilibration between 
CO2  species  is  not  complete  during  the  transit  through  the  pulmonary 
capillary.  The  reflection  of  these  activities  is  also  inhibition  of  HCO3
- 
transport. The decrease in the rate of HCO3
- dehydration after treatment 
with Acz increased the erythrocyte [HCO3
-] and consequently reduced the 
plasma [HCO3
-] (Swenson 1998, Swenson 2000).   37
Erythrocyte  volume  decreased  across  the  lung  during  exercise  was 
attenuated by AczTr. There are several active and passive mechanism that 
regulate  erythrocyte  volume,  which  are  manifest  as  the  erythrocyte 
regulatory  volume  increase  in  peripheral  tissues  and  by  the  erythrocyte 
regulatory volume decrease across the lung (Fievet et al. 1990, Gibson et 
al. 1993, Gibson et al. 1995, Honess et al. 1996, Speake et al. 1997; Juel et 
al. 1999, Gibson et al. 2000). Based on our results it appears that the major 
reason for incomplete or absent volume decrease across the lung in AczTr 
is  due  to  depressed  erythrocyte  [Cl
-]  efflux  and  slowed  CO2 
dehydration/hydration reaction or Jacobs-Stewart cycle. 
Plasma  SIDV-A  (plasma  strong  ion  difference  across  the  lung)  had  a 
positive value in Con and AczTr indicating a reduction in SID across the 
lung. This was in greater part driven by an influx of Cl
- from erythrocytes 
to  initiate the Jacobs-Stewart cycle (Jacobs and Stewart 1942, Jennings 
1989),  which  substantially  decreases  erythrocyte  [SID]V-A.  Carbonic 
anhydrase inhibition prevented efflux of Cl
- from erythrocytes, hence the 
substantially decreased erythrocyte [SID]V-A in AczTr. With exception of 
La
-, other strong ions showed the tendency to counteract changes caused by 
CO2 retention and Cl
- efflux attenuation. 
At rest plasma [H
+]V-A was similar in Con and AczTr, indicating that 
elimination  of  CO2  was increased due to stimulated ventilation kinetics 
(Swenson  and  Maren  1978,  Ward  et al. 1983, Kowalchuk et al. 1994). 
During exercise in Con, despite a concomitant plasma SID decrease across 
the  lung,  plasma  [H
+]V-A  remained  strongly  positive  (indicating  a  [H
+] 
reduction in plasma across the lung). This was due to a substantial PCO2 
reduction and Cl
- efflux (and SID increase) across the lung. Conversely, in 
AczTr  plasma  [H
+]V-A  was  affected  by  CO2  species  retention  and 
erythrocyte Cl
- shift impairment and was lower than in Con. 
CO2 and Cl
- changes in erythrocytes across the lung appear to be the 
major  contributors  to  acid-base  and  ions  balance,  as  well  as  volume 
changes across the lung, in exercising horses, and most likely also in other 
mammalian species. Therefore, the hypothesis that chloride shift and the 
CO2/HCO
3−/H
+  interconversion  are  important  for  pulmonary  circulation 
transvascular fluid fluxes was confirmed. 
Effect of furosemide on transvascular fluid fluxes across the 
lung in exercising horses (paper IV) 
Furosemide is prescribed for management of racehorses experiencing 
EIPH (Arthur 1991). The dose used in this study was 250 mg administered   38
4 hours before exercise, according to limits imposed in Canada and some 
US horse racing jurisdictions. Treatment with Fur attenuates the exercise-
induced rise in pulmonary capillary blood pressure, which is believed to 
decrease  the  occurrence  of  EIPH  via  the  reduction  of  the  transmural 
hydrostatic  pressures  in  pulmonary  capillaries  (Manohar  1993,  1994, 
Manohar et al. 1994, Kindig et al. 2001). 
In this study treatment with 250 mg of Fur (FurTr) four hours before the 
onset of exercise had no effect on JV-A and did not affect the duration of 
exercise at 80% VO2max to fatigue (figure 5).  
 
Figure 5. Fluid flux from/into the pulmonary vasculature (JV-A) at rest, during exercise and 
recovery. Values are means ± SE (n=6). Ftg: fatigue. Positive values indicate decrease of 
JV-A across the lung. Negative value indicate increase of JV-A across the lung. 
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As  well,  treatment  with  Fur  did  not  affect  erythrocyte  fluid  release 
(figure 6). 
However, treatment with Fur reduced Q during exercise: cardiac output 
increased from 20.9 ±6 L/min and 19.4 ±9 L/min at rest in control and 
FurTr, respectively, to 299.9 ±16.6 L/min and 247.9 ±13.9 L/min at the 
first min of exercise in control and FurTr, respectively (P < 0.0001). It 
returned to resting values during recovery. During exercise Q was lower in 
FurTr compare to Con (P = 0.01). 
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Figure 6. Erythrocyte fluid fluxes (JER) at rest, during exercise and recovery. Values are 
means ± SE (n=6). Ftg: fatigue. Positive values indicate decrease of JER across the lung. 
Negative values indicate increase of JER across the lung  
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This study suggests that the focus with regards to investigation into the 
initiation and maintenance of pulmonary circulation transvascular fluxes 
should  in  greater  part  shift  from  pulmonary  circulation  pressures  to 
erythrocyte  volume  regulation.  Most  ion  exchange  mechanisms  in 
erythrocytes  are  part  of  the  erythrocyte  volume  regulation  mechanisms 
(Guizouarn et al 2001). Na
+/K
+/Cl
- co-transport, which carries the major 
diuretic  effect  of  Fur,  does  not  poses  significant  volume  regulation 
properties, whereas chloride shift (Hamburger shift) across the erythrocyte 
membrane (Bretcher 1971, Lambert and Lowe 1980, Kracke and Dunham 
1987) can contribute substantially to pulmonary transvascular fluid fluxes. 
Furosemide  blocks  anion  exchange  mechanisms  (Hamburger  shift)  in 
erythrocytes (Lambert and Lowe 1980); however, water movement across 
the  erythrocyte  membrane  in  this  study  was  similar  in  Con  and  FurTr. 
Therefore,  at  a  dose  of  250mg  Fur  activity  on  the  erythrocyte  anion 
exchange  mechanisms  also  seems  unlikely  to  be  of  significance  in 
exercising horses four hours after the intravenous administration. 
Cardiac output indicates the changes in pulmonary capillary recruitment 
and/or dilatation and the increase in the pulmonary surface area during 
exercise  (Bake  et  al.  1968,  Hlastala  et  al.  1996).  Furosemide  caused 
decrease  in  Q,  which  indicates  a  decrease  in  pulmonary  capillary 
recruitment,  less  explicit  capillary  recruitment  and  consequent  smaller 
transmural hydrostatic pressures compare to Con. However, this did not   40
affect JV-A. It is then unlikely that horses affected by EIPH would benefit 
from treatment with 250mg of furosemide four hours before exercise if 
current etiology theory of the disease is relevant, because Starling forces 
most  probably  retain  their  effect  on  pre-  and  post  pulmonary  capillary 
vessels. Pulmonary capillaries are very resilient to leakage and changes in 
transmural  hydrostatic  forces  (Effros  and  Parker,  2009).  The  filtration 
coefficient of the pulmonary capillaries is smaller than that of the extra-
alveolar vessels (Schneeberger and Karnovsky 1976, Bhattacharya 1988, 
Maggiorini et al. 2001). Therefore, the dynamics of water movement in the 
pulmonary  circulation  are  complex  events  encompassing  gas  exchange 
mechanisms,  erythrocyte  volume  regulation  and  only  then  Starling’s 
forces.  
Methodological considerations (all papers) 
In  our  studies  we  have  measured  total  transvascular  fluxes  from the 
pulmonary circulation, which include fluid that contributes to increases in 
lung  lymph  flow  and  total  lung  water.  Lung  lymph  flow  studies 
implementing different experimental conditions such as exercise (Coates et 
al. 1984, Newman et al. 1988), left atrial balloon obstruction  (Parker et al. 
1981), hypoxia (Dauber and Weil 1983), or 100% O2 inhalation (Newman 
et al. 1983) to induce pulmonary vascular pressure changes or increase 
lung vascular permeability, would require better defined attention to the 
uncertainty concerning the tissues drained by the lymphatics and the effect 
of the lymph nodes themselves on lymph constituents. On the other hand, 
gravimetric  lung  fluid  dynamic  studies  only  detect  variations  in  the 
presence  of  lung  water  and  are  unable  to  account  for  alterations  when 
changes are to be contributed to the vascular, interstitial, and/or cellular 
compartments  in  lungs  (Lin  et  al.  1998).  They  also  require  static 
experimental  conditions  (Hanel  et  al.  2003).  In  contrast  to  detecting 
changes  in  lung  fluid  dynamics  by  lung  lymph  flow  or  pulmonary 
gravimetric  studies  we  were  able  to  measure  the  total  fluid  flux  from 
pulmonary  circulation  from  changes  in  BV  in  vivo  and  in  dynamic 
experimental settings.  
Plasma volume changes associated with exercise were calculated using 
plasma  protein  concentration  as  described  by  Dill  and  Costill  (1974) 
(equation 7). Plasma volume changes were then calculated relative to Hct 
changes in venous and the arterial blood (equation 8) to account for the 
very  unlikely  event  of:  1)  relative  plasma  volume  changes  (Hct   41
decrease/erythrocyte  removal)  or  2)  absolute  plasma  volume  changes 
(plasma leakage from the pulmonary circulation). 
Hemoglobin  is  confined  strictly  to  erythrocytes  and  should  not  be 
affected  by  physiologically  derived  stress  or  by  most  pathologically 
derived  alterations.  Therefore,  erythrocyte  volume  across  the  lung  was 
calculated  based  on  changes  in  Hb  (equation  9)  (Costill  et  al.  1974). 
Equation  9  was  also  adjusted  for  possible  Hct  changes  across  the lung 
when used for blood volume calculations. 
 Methods  for  calculation  of  blood  volume  changes  used  in  this 
experiment are precise (coefficient of variance from 0.7 to 2.4%) and are 
able to measure small changes (Dill and Costill 1974, Costill et al. 1974, 
Harrison  1985).  They  provide  accurate  results  acutely  in  exercising 
subject, which would perhaps include other animals and humans, without 
need for chronic instrumentation, or, potentially, at patient’s bedside, with 
chronic  instrumentation  for  continuous  monitoring  of  volume  changes 
across the lung. 
In conclusion, methods for calculation of blood volume changes used in 
these  experiments  are  simple  and  have  been  validated  and  published 
previously (Dill and Costill 1974, Costill et al. 1974, Harrison 1985). 
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Summary and conclusions 
Regarding the pulmonary circulation transvascular fluid fluxes (JV-A): 
 
1.  During  exertion  in  horses  approximately  4%  of  Q  moves  from 
pulmonary circulation into the pulmonary interstitium, 
2.  Erythrocyte volume regulation/fluid release across the lung is the most 
important contributor to JV-A, 
3.  JV-A commence with respiratory gas exchange, 
4.  JV-A appear to be largely insensible to changes in pulmonary circulation 
transmural hydrostatic pressures during exercise,  
5.  CO2 and Cl
- changes in erythrocytes across the lung appear to be the 
major contributors to acid-base and ions balance, as well as pulmonary 
circulation transvascular fluid fluxes, 
6.  Furosemide at the dose of 250 mg given four hours before exercise does 
not change erythrocyte volume regulation/fluid release across the lung, 
7.  Furosemide at the dose of 250 mg given four hours before exercise does 
not affect JV-A in pulmonary circulation despite the decreased Q, 
8.  Erythrocyte  volume  regulation/fluid  release  across  the  lung  is  more 
relevant  to  JV-A  than  pulmonary  circulation  transmural  hydrostatic 
forces. 
9.  The data in this thesis is a paradigm change in the interpretation of 
pulmonary  circulation  transvascular  fluid  fluxes  away  from  the 
traditional  interpretation,  which  is  based  on  Starling’s  principles,  to 
major influences of the erythrocyte volume decrease across the lung via 
the  Jacobs-Stewart  cycle  and  chloride  (anion)  exchanger  (Band  3 or 
AE1).       44
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